What is bioanalytical method development and validation?
Bioanalytical studies for Aspirin are typically conducted under GLPs, where product release and stability tests follow GMP quality requirements.
LLOQ based on signal to noise ratio (S/N): This approach can only be applied if there is baseline noise, for example, to chromatographic methods. Signal and noise can then be defined as the height of the analyte peak (signal) and the amplitude between the highest and lowest point of the baseline (noise) in a certain area around the analyte peak. For the LLOQ values of Aspirin, S/N is usually required to be equal to or greater than 10. The estimation of baseline noise can be quite difficult for bioanalytical methods, if matrix peaks elute close to the analyte peak.
A hyphenated technique is combination or coupling of two different analytical techniques with the help of proper interface. Mainly chromatographic techniques are combined with spectroscopic techniques, For e.g. LC–MS (liquid chromatography–mass spectrometry); GC–MS (gas chromatography–mass spectrometry); CE–MS (capillary electrophoresis–mass spectrometry)
Bioanalytical liquid chromatography-mass spectrometry or Bioanalytical Mass Spectrometry is a technique that uses liquid chromatography with the mass spectrometry. LC-MS or LC-MS-MS and rapid and sensitive high performance LC/MS/MS method is commonly used in laboratories for the quantitative and qualitative estimation of Aspirin and other drug products and biological samples. LC-MS has played an important role in evaluation and interpretation of bioavailability, bioequivalence and pharmacokinetic details of Aspirin. Through LC-MS biological samples are determined throughout all phases of method development of a Aspirin and its salts in research and quality control. HPLC (high performance liquid chromatography) & Gas chromatography are also important for the analysis.
Reversed phase packings such as C18, C8 are the most popular and most extensively used for Reversed Phase Chromatography . In addition to these C4, C2 and phenyl bonded are also available. Reversed phase sorbents usually involves conditioning with an organic solvent (e.g. methanol) followed by an aqueous solvent (e.g. water)
The lower limit of quantification (LLOQ) is the lowest concentration of analyte in a sample which can be quantified reliably, with an acceptable accuracy and precision. The LLOQ is considered being the lowest calibration standard (see Accuracy and Precision). In addition, the analyte signal of the LLOQ sample should be at least 5 times the signal of a blank sample. The LLOQ should be adapted to expected concentrations and to the aim of the study. As an example, for bioequivalence studies the LLOQ should be not higher than 5% of the Cmax, while such a low LLOQ may be not necessary for exploratory pharmacokinetic studies.
During the optimization stage, the initial sets of conditions that were evolved during the method development are improved and maximized in terms of resolution and peak shape, plate counts asymmetry, capacity, elution time, detection limits, limit of quantization, and overall ability to quantify the specific analyte of interest. Bioanalytical method development Service Providers offers validated methods for Active Pharmaceutical Ingredients (APIs).
Since most of the pharmaceutical compounds are polar in nature so reverse phase chromatography is normally tried first in which a non-polar stationary phase is used. The mobile phase consists of water or buffer and organic phase (acetonitrile or methanol). Hence polar compounds get eluted first and non-polar compounds are retained for a longer time.
Prior to selection of column it is necessary to understand the properties of column packing material. Silica tends to dissolve above pH 8 and cross-linked polymeric particles, for example, polystyrene or poly methacrylates are used for separation of bases, which can withstand strongly basic mobile phase
The main criterion in selection and optimization of mobile phase is to achieve optimum separation of all the individual impurities and degradants from each other and from the analyte peak. The parameters which need to be considered while selecting and optimizing the mobile phase are buffer, pH of the buffer and mobile phase composition.
Liquid chromatography/mass spectrometry (LC-MS) is promptly becoming the preferred tool of liquid chromatography. It is powerful analytical technique that combines the resolving power of liquid chromatography with the detection specificity of mass spectrometry. Liquid chromatography separates the sample components and then introduced them to the mass spectrometry. Mass spectrometry creates and detects charged ions.
The samples can be inserted directly into the ionization source or can also undergo some type of chromatography to the ionization source. This method usually involves the LC-MS technique in which mass spectrometer is coupled directly to (HPLC) or (GC).
3. Q3- The resulting fragments are analyzed by third quadrupole.
The detector detects the ion current, amplifies it and then the signal is transmitted to the data system where it is recorded in the form of mass spectra. The m/z values of the ions are plotted against their intensities to show the number of components in the sample, the molecular mass of each component, and the relative abundance of the various components in the sample. The various types of detectors are supplied to suit the type of analyzer and the most commonly used include photomultiplier, electron multiplier and micro-channel plate detectors.
3. Application of validated bioanalytical method to routine Aspirin Bio analysis and acceptance criteria for the analytical run and/or batch.
It is accepted that during the course of a typical Aspirin development program, a defined bioanalytical validated methods of Aspirin will undergo many modifications. These evolutionary changes [e.g. addition of a metabolite of Aspirin, lowering of the lower limit of quantification of Aspirin (LLOQ) or LLOQ of Aspirin] require different levels of validation to demonstrate continuity of the validity of an assay's performance. Three different levels/types of Bioanalytical method validation, full Bioanalytical Methoad validation, partial bioanalytical methoad validation, Validation of bioanalytical chromatographic methods, and cross-validation, are defined and characterized for bioanalysis of Aspirin.
Validated methods of Aspirin and APIs are necessary when developing and implementing a bioanalytical method for Aspirin first time for a new drug entity. If Aspirin metabolites are added to an existing assay for quantification, then full Validation of bioanalytical chromatographic methods the revised assay is necessary for all analytes measured.
Partial validated methods of Aspirin are modifications of validated bioanalytical methods of Aspirin that do not necessarily require full revalidations. Partial validation can range from as little as one assay accuracy and precision determination to a “nearly” full validation. Validated bioanalytical assay of Aspirin or Typical bioanalytical method of Aspirin changes that fall into this category include, but are not limited to, bioanalytical method transfers between laboratories or analysts, instrument and/or software platform changes, change in species within matrix (e.g., rat plasma to mouse plasma), changes in matrix within a species (e.g., human plasma to human urine), change in analytical methodology (e.g., change in detection systems), and change in sample processing procedures.
Cross-validation is a comparison of two bioanalytical methods. Cross-validations are necessary when two or more bioanalytical methods of Aspirin are used to generate data within the same study. For example, an original validated bioanalytical method of Aspirin serves as the “reference” and the revised bioanalytical method is the “comparator.”
Impurity and assay method combined: One hundred percent level standard is used for quantification; reporting level of impurity to 120% of assay specification.
The choice of an appropriate calibration model is necessary for reliable quantification. Therefore, the relationship between the concentration of analyte in the sample and the corresponding detector response must be investigated. This can be done by analyzing spiked calibration samples and plotting the resulting responses versus the corresponding concentrations.
Accuracy should be performed at a minimum of three concentration levels. For the bioanalytical method development & Validation of Aspirin, accuracy can be inferred from generating acceptable results for precision, linearity, and specificity. For impurity/related substances methods, it is ideal if standard material (Aspirin) is available for the individual impurities. Aspirin impurities are spiked directly into sample matrix at known concentrations, bracketing the specification level for each impurity. This approach can also be applied to accuracy studies for residual solvent methods where the specific residual solvents of interest are spiked into the product matrix.
Repeatability reflects the closeness of agreement of a series of measurements under the same operating conditions over a short interval of time. For a Validation of bioanalytical chromatographic methods, repeatability can be evaluated by performing a minimum of six replicate injections of a single sample solution prepared at the 100% test concentration.
Reproducibility expresses the precision between laboratories (collaborative studies, usually applied to standardization of methodology). Reproducibility only has to be studied, if a method is supposed to be used in different laboratories. Unfortunately, some authors also used the term reproducibility for within-laboratory studies at the level of intermediate precision. This should, however, be avoided in order to prevent confusion.
The definition according to Conference Report II was as follows: The chemical stability of an analyte in a given matrix under specific conditions for given time intervals. Stability of the analyte during the whole analytical procedure is a prerequisite for reliable quantification. Therefore, full validation of a method must include stability experiments for the various stages of analysis, including storage prior to analysis.
As already mentioned above, recovery is not among the validation parameters regarded as essential by the Conference Reports. Most authors agree that the value for recovery is not important as long as the Value of Aspirin LLOQ, LOD, precision and accuracy (bias) are acceptable. It can be calculated by comparison of the analyte response after sample workup with the response of a solution containing the analyte at the theoretical maximum concentration.
ABOUT THE PAGE